Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998–2017

Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998–2017

<strong>Background </strong>Prostate cancer is a leading cause of cancer- related death. Interpreting the results from trials of screening with prostate-specific antigen (PSA) is complex in terms of defining optimal prostate cancer screening policy. <br> <strong>Aim</stron...

Bibliográfalaš dieđut
Váldodahkkit:	Clift, AK, Coupland, CAC, Hippisley-Cox, J
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Royal College of General Practitioners 2021

Geahča maid

COVID-19 mortality risk in Down syndrome: results from a cohort study of 8 million adults
Dahkki: Clift, AK, et al.
Almmustuhtton: (2020)

Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study
Dahkki: Jack, RH, et al.
Almmustuhtton: (2020)

The Role of Prostate-Specific Antigen in Prostate Cancer Screening
Dahkki: Constantin Traian Vasile, et al.
Almmustuhtton: (2014-06-01)

Trends in antidepressant prescriptions in children and young people in England, 1998-2017: protocol of a cohort study using linked primary care and secondary care datasets
Dahkki: Jack, RH, et al.
Almmustuhtton: (2019)

Optimal use of prostate specific antigen for prostate cancer screening
Dahkki: Miočinović Ranko, et al.
Almmustuhtton: (2013-01-01)

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
Dahkki: Bangma, C, et al.
Almmustuhtton: (2010)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
Dahkki: Avery, K, et al.
Almmustuhtton: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
Dahkki: Avery, K, et al.
Almmustuhtton: (2012)

Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
Dahkki: Sonja Cabarkapa, et al.
Almmustuhtton: (2016-12-01)

Bioimpedance and chronoamperometry as an adjunct to prostate-specific antigen screening for prostate cancer
Dahkki: Abreu DS
Almmustuhtton: (2011-04-01)

Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options
Dahkki: Tushar Aditya Narain, et al.
Almmustuhtton: (2022-01-01)

Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study
Dahkki: Hippisley-Cox, J, et al.
Almmustuhtton: (2023)

Prostate-specific antigen screening for prostate cancer: An old but never-ending story
Dahkki: Sun Il Kim
Almmustuhtton: (2023-09-01)

Screening of Prostate Cancer by Prostate Specific Antigen and its Prevalence in Jammu Region
Dahkki: Rachna Sabharwal, et al.
Almmustuhtton: (2016-01-01)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
Dahkki: Nouira Yassin, et al.
Almmustuhtton: (2010-12-01)

Analysis of incidence of motor neuron disease in England 1998–2019: use of three linked datasets
Dahkki: Burchardt, JM, et al.
Almmustuhtton: (2022)

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
Dahkki: Yasuhide Kitagawa, et al.
Almmustuhtton: (2014-12-01)

Discoveries and application of prostate-specific antigen, and some proposals to optimize prostate cancer screening
Dahkki: Tokudome S, et al.
Almmustuhtton: (2016-05-01)

Prostatic specific antigen for prostate cancer detection
Dahkki: Lucas Nogueira, et al.
Almmustuhtton: (2009-10-01)

Benign prostatic hyperplasia and prostate-specific antigen
Dahkki: Pejčić Tomislav, et al.
Almmustuhtton: (2015-01-01)

Value of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Detection of Prostate Cancer in an Iranian Population of Men
Dahkki: Mahyar Ghafoori, et al.
Almmustuhtton: (2009-08-01)

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
Dahkki: Sinan Avci, et al.
Almmustuhtton: (2020-04-01)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
Dahkki: Jeremy YC Teoh, et al.
Almmustuhtton: (2017-01-01)

Prostate Cancer: Burden and Correlation with Prostate Specific Antigen Among Screened African Men in Tanzania
Dahkki: Ngowi BN, et al.
Almmustuhtton: (2024-11-01)

Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort
Dahkki: Clift, AK, et al.
Almmustuhtton: (2021)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
Dahkki: Ahmad Anies Shahab, et al.
Almmustuhtton: (2013-03-01)

The Impact of Prostate-Specific Antigen Screening on Prostate Cancer Incidence and Mortality in China: 13-Year Prospective Population-Based Cohort Study
Dahkki: Xiaohao Ruan, et al.
Almmustuhtton: (2024-01-01)

Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch database
Dahkki: Liao, W, et al.
Almmustuhtton: (2023)

Biology of prostate-specific antigen
Dahkki: Lilja, H
Almmustuhtton: (2003)

Biology of prostate-specific antigen.
Dahkki: Lilja, H
Almmustuhtton: (2003)

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
Dahkki: Sirwan M. Muhammad, et al.
Almmustuhtton: (2013-09-01)

Predicting the risk of Chronic Kidney Disease in Men and Women in England and Wales: prospective derivation and external validation of the QKidney<sup>® </sup>Scores
Dahkki: Coupland Carol, et al.
Almmustuhtton: (2010-06-01)

Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
Dahkki: Hugosson, J, et al.
Almmustuhtton: (2003)

Application and optimization of prostate-specific antigen screening strategy in the diagnosis of prostate cancer: a systematic review
Dahkki: Zhengchao Zhang, et al.
Almmustuhtton: (2024-01-01)

CUT-OFF VALUES OF PROSTATE SPECIFIC ANTIGEN DENSITY– AN EFFECTIVE SCREENING MARKER BEFORE PROSTATE BIOPSY
Dahkki: Zujaja Hina Haroon, et al.
Almmustuhtton: (2022-03-01)

Brief report: Impact of healthcare quality on prostate specific antigen screening for the early detection of prostate cancer
Dahkki: Michael E. Rezaee, et al.
Almmustuhtton: (2019-06-01)

Prostate-specific antigen screening of men with lower urinary tract symptoms (opportunistic screening) and of asymptomatic men undergoing executive health check: an audit from two institutions
Dahkki: Anil Mandhani, et al.
Almmustuhtton: (2021-01-01)

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
Dahkki: Roobol, M, et al.
Almmustuhtton: (2009)

Ethnic disparities in COVID-19 outcomes: a multinational cohort study of 20 million individuals from England and Canada
Dahkki: Zaccardi, F, et al.
Almmustuhtton: (2023)

Sickle cell disorders and severe COVID-19 outcomes: a cohort study
Dahkki: Clift, AK, et al.
Almmustuhtton: (2021)